3645 results for «566»
3645 results
Think SMART! Valve precision and performance matters
05 Oct 2024 – From AICT-AsiaPCR 2024
Explore the impact of the SMART trial results on your practice and decision-making in TAVI. Learn how to achieve precision and control in challenging anatomy with the Evolut FX Platform. Discover the new Evolut FX System and how it can deliver optimal procedural outcomes for all...
Stroke and peripheral interventions: Navigating complex cases with expertise
05 Oct 2024 – From AICT-AsiaPCR 2024
This session showcases a remarkable collection of clinical cases from the AICT-AsiaPCR 2024 conference, focusing on stroke and peripheral interventions. Witness the management of diverse vascular pathologies, including hemoptysis in patent ductus arteriosus, retrograde peripheral CTO intervention, and acute limb ischemia. Gain valuable insights into navigating...
Bifurcation PCI with TAP technique - LIVE case
05 Oct 2024 – From AICT-AsiaPCR 2024
A 72-year-old lady with dyslipidemia, hypertension and aspirin intolerance presented an NSTEMI. The coronary angiography showed a distal CX occlusion and a long calcified significant stenosis on proximal LAD with LAD/D3 bifurcation lesion, and a reduced LV function (47%).
Watch the operators as they perform an important...
How should I treat complex lesion from the intracoronary imaging view?
05 Oct 2024 – From AICT-AsiaPCR 2024
Intracoronary imaging plays a crucial role in guiding treatment strategies for complex lesions. This session delves into the use of various imaging modalities, such as IVUS and OCT, to optimize PCI outcomes. Explore real-world case examples, including a sudden coronary arrest caused by focal stenosis with...
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
